Département de pharmacologie et toxicologie

Equipe principale | Groupe Bonny | Groupe Broillet | Groupe Cotecchia | Groupe Diviani | Groupe Firsov | Groupe Hummler | Groupe Katanaev | Groupe Kellenberger | Groupe Ocampo | Groupe Rossier | Groupe Schild | Groupe Staub
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


76 publications

2017 | 2013 | 2012 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 |
 
Ezrin directly interacts with AQP2 and promotes its endocytosis.
Li W., Jin W.W., Tsuji K., Chen Y., Nomura N., Su L., Yui N., Arthur J., Cotecchia S., Paunescu T.G. et al., 2017/09/01. Journal of cell science, 130 (17) pp. 2914-2925. Peer-reviewed.
 
A-kinase-anchoring protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophy.
del Vescovo C.D., Cotecchia S., Diviani D., 2013. Molecular and Cellular Biology, 33 (1) pp. 14-27. Peer-reviewed.
Protein-protein interactions at the adrenergic receptors.
Cotecchia S., Stanasila L., Diviani D., 2012. Current Drug Targets, 13 (1) pp. 15-27.
 
Constitutive activity and inverse agonism at the α(₁a) and α(₁b) adrenergic receptor subtypes.
Cotecchia S., 2010. Methods in Enzymology, 485 pp. 123-138.
The α1-adrenergic receptors: diversity of signaling networks and regulation.
Cotecchia S., 2010. Journal of Receptor and Signal Transduction Research, 30 (6) pp. 410-419. Peer-reviewed.
 
Enhanced vascular contractility in alpha1-adrenergic receptor-deficient mice.
Sanbe A., Tanaka Y., Fujiwara Y., Miyauchi N., Mizutani R., Yamauchi J., Cotecchia S., Koike K., Tsujimoto G., Tanoue A., 2009. Life Sciences, 84 (21-22) pp. 713-718. Peer-reviewed.
 
Different internalization properties of the alpha1a- and alpha1b-adrenergic receptor subtypes: the potential role of receptor interaction with beta-arrestins and AP50.
Stanasila L., Abuin L., Dey J., Cotecchia S., 2008. Molecular Pharmacology, 74 (3) pp. 562-573.
 
Neuroendocrine deregulation of food intake, adipose tissue and the gastrointestinal system in obesity and metabolic syndrome.
Garruti G., Cotecchia S., Giampetruzzi F., Giorgino F., Giorgino R., 2008. Journal of Gastrointestinal and Liver Diseases, 17 (2) pp. 193-198. Peer-reviewed.
 
Alpha1-adrenoceptor-dependent vascular hypertrophy and remodeling in murine hypoxic pulmonary hypertension.
Faber J.E., Szymeczek C.L., Cotecchia S., Thomas S.A., Tanoue A., Tsujimoto G., Zhang H., 2007. American Journal of Physiology. Heart and Circulatory Physiology, 292 (5) pp. H2316-H2323. Peer-reviewed.
 
Alpha1-adrenoceptors are required for normal male sexual function.
Sanbe A., Tanaka Y., Fujiwara Y., Tsumura H., Yamauchi J., Cotecchia S., Koike K., Tsujimoto G., Tanoue A., 2007. British Journal of Pharmacology, 152 (3) pp. 332-340.
 
Blockade of both alpha1A- and alpha1B-adrenergic receptor subtype signaling is required to inhibit neointimal formation in the mouse femoral artery.
Hosoda C., Hiroyama M., Sanbe A., Birumachi J., Kitamura T., Cotecchia S., Simpson P.C., Tsujimoto G., Tanoue A., 2007. American Journal of Physiology. Heart and Circulatory Physiology, 293 (1) pp. H514-H519. Peer-reviewed.
 
Constitutive activity and inverse agonism at the alpha1adrenoceptors.
Cotecchia S., 2007. Biochemical Pharmacology, 73 (8) pp. 1076-1083.
 
Expression and secretion of the atrial natriuretic peptide in human adipose tissue and preadipocytes.
Garruti G., Giusti V., Nussberger J., Darimont C., Verdumo C., Amstutz C., Puglisi F., Giorgino F., Giorgino R., Cotecchia S., 2007. Obesity, 15 (9) pp. 2181-2189. Peer-reviewed.
 
The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy.
Appert-Collin A., Cotecchia S., Nenniger-Tosato M., Pedrazzini T., Diviani D., 2007. Proceedings of the National Academy of Sciences of the United States of America, 104 (24) pp. 10140-10145.
 
Ezrin directly interacts with the alpha1b-adrenergic receptor and plays a role in receptor recycling.
Stanasila L., Abuin L., Diviani D., Cotecchia S., 2006. Journal of Biological Chemistry, 281 (7) pp. 4354-4363. Peer-reviewed.
 
Correlation between vasoconstrictor roles and mRNA expression of alpha1-adrenoceptor subtypes in blood vessels of genetically engineered mice.
Hosoda C., Tanoue A., Shibano M., Tanaka Y., Hiroyama M., Koshimizu T.A., Cotecchia S., Kitamura T., Tsujimoto G., Koike K., 2005. British Journal of Pharmacology, 146 (3) pp. 456-466.
 
Historical review: Negative efficacy and the constitutive activity of G-protein-coupled receptors.
Costa T., Cotecchia S., 2005. Trends in Pharmacological Sciences, 26 (12) pp. 618-624.
 
Paired activation of two components within muscarinic M3 receptor dimers is required for recruitment of beta-arrestin-1 to the plasma membrane.
Novi F., Stanasila L., Giorgi F., Corsini G.U., Cotecchia S., Maggio R., 2005. Journal of Biological Chemistry, 280 (20) pp. 19768-19776. Peer-reviewed.
 
Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
Sarang Z., Molnár P., Németh T., Gomba S., Kardon T., Melino G., Cotecchia S., Fésüs L., Szondy Z., 2005. Hepatology, 42 (3) pp. 578-587.
 
Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation.
Hosoda C., Koshimizu T.A., Tanoue A., Nasa Y., Oikawa R., Tomabechi T., Fukuda S., Shinoura H., Oshikawa S., Takeo S. et al., 2005. Molecular Pharmacology, 67 (3) pp. 912-922.
 
5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants.
Auclair A., Drouin C., Cotecchia S., Glowinski J., Tassin J.P., 2004. European Journal of Neuroscience, 20 (11) pp. 3073-3084.
 
Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex.
Diviani D., Abuin L., Cotecchia S., Pansier L., 2004. EMBO Journal, 23 (14) pp. 2811-2820.
 
Critical role for the alpha-1B adrenergic receptor at the sympathetic neuroeffector junction.
Townsend S.A., Jung A.S., Hoe Y.S., Lefkowitz R.Y., Khan S.A., Lemmon C.A., Harrison R.W., Lee K., Barouch L.A., Cotecchia S. et al., 2004. Hypertension, 44 (5) pp. 776-782.
 
Gene deletion of dopamine beta-hydroxylase and alpha1-adrenoceptors demonstrates involvement of catecholamines in vascular remodeling.
Zhang H., Cotecchia S., Thomas S.A., Tanoue A., Tsujimoto G., Faber J.E., 2004. American Journal of Physiology. Heart and Circulatory Physiology, 287 (5) pp. H2106-H2114. Peer-reviewed.
 
Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype.
Burcelin R., Uldry M., Foretz M., Perrin C., Dacosta A., Nenniger-Tosato M., Seydoux J., Cotecchia S., Thorens B., 2004. Journal of Biological Chemistry, 279 (2) pp. 1108-1115.
 
Structural determinants involved in the activation and regulation of G protein-coupled receptors: lessons from the alpha1-adrenegic receptor subtypes.
Cotecchia S., Stanasila L., Diviani D., Björklöf K., Rossier O., Fanelli F., 2004. Biology of the Cell, 96 (5) pp. 327-333.
 
Constitutively active G protein-coupled receptor mutants: implications on receptor function and drug action.
Cotecchia S., Fanelli F., Costa T., 2003. Assay and Drug Development Technologies, 1 (2) pp. 311-316.
 
Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization.
Stanasila L., Perez J.B., Vogel H., Cotecchia S., 2003. Journal of Biological Chemistry, 278 (41) pp. 40239-40251. Peer-reviewed.
 
The adaptor complex 2 directly interacts with the alpha 1b-adrenergic receptor and plays a role in receptor endocytosis.
Diviani D., Lattion A.L., Abuin L., Staub O., Cotecchia S., 2003. Journal of Biological Chemistry, 278 (21) pp. 19331-19340. Peer-reviewed.
 
The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse.
O'Connell T.D., Ishizaka S., Nakamura A., Swigart P.M., Rodrigo M.C., Simpson G.L., Cotecchia S., Rokosh D.G., Grossman W., Foster E. et al., 2003. Journal of Clinical Investigation, 111 (11) pp. 1783-1791.
 
Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates.
Drouin C., Darracq L., Trovero F., Blanc G., Glowinski J., Cotecchia S., Tassin J.P., 2002. Journal of Neuroscience, 22 (7) pp. 2873-2884.
 
Beta(1)-selective agonist (-)-1-(3,4-dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(-)-RO363] differentially interacts with key amino acids responsible for beta(1)-selective binding in resting and active states.
Sugimoto Y., Fujisawa R., Tanimura R., Lattion A.L., Cotecchia S., Tsujimoto G., Nagao T., Kurose H., 2002. Journal of Pharmacology and Experimental Therapeutics, 301 (1) pp. 51-58. Peer-reviewed.
 
Cardiovascular influences of alpha1b-adrenergic receptor defect in mice.
Vecchione C., Fratta L., Rizzoni D., Notte A., Poulet R., Porteri E., Frati G., Guelfi D., Trimarco V., Mulvany M.J. et al., 2002. Circulation, 105 (14) pp. 1700-1707.
 
Co- and posttranslational modification of the alpha(1B)-adrenergic receptor: effects on receptor expression and function.
Björklöf K., Lundström K., Abuin L., Greasley P.J., Cotecchia S., 2002. Biochemistry, 41 (13) pp. 4281-4291.
 
D-amphetamine fails to increase extracellular dopamine levels in mice lacking alpha 1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release.
Auclair A., Cotecchia S., Glowinski J., Tassin J.P., 2002. Journal of Neuroscience, 22 (21) pp. 9150-9154.
 
Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation.
Greasley P.J., Fanelli F., Rossier O., Abuin L., Cotecchia S., 2002. Molecular Pharmacology, 61 (5) pp. 1025-1032.
 
Mutations inducing divergent shifts of constitutive activity reveal different modes of binding among catecholamine analogues to the beta(2)-adrenergic receptor.
Del Carmine R., Ambrosio C., Sbraccia M., Cotecchia S., Ijzerman A.P., Costa T., 2002. British Journal of Pharmacology, 135 (7) pp. 1715-1722.
 
Role of brain alpha 1B-adrenoceptors in modafinil-induced behavioral activity.
Stone E.A., Cotecchia S., Lin Y., Quartermain D., 2002. Synapse, 46 (4) pp. 269-270.
 
The alpha1b-adrenergic receptor subtype: molecular properties and physiological implications.
Cotecchia S., Björklöf K., Rossier O., Stanasila L., Greasley P., Fanelli F., 2002. Journal of Receptor and Signal Transduction Research, 22 (1-4) pp. 1-16.
 
A behavioral study of alpha-1b adrenergic receptor knockout mice: increased reaction to novelty and selectively reduced learning capacities.
Spreng M., Cotecchia S., Schenk F., 2001. Neurobiology of Learning and Memory, 75 (2) pp. 214-229. Peer-reviewed.
 
A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors.
Hein P., Goepel M., Cotecchia S., Michel M.C., 2001. Naunyn-schmiedeberg's Archives of Pharmacology, 363 (1) pp. 34-39.
 
Mutational and computational analysis of the alpha(1b)-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling.
Greasley P.J., Fanelli F., Scheer A., Abuin L., Nenniger-Tosato M., DeBenedetti P.G., Cotecchia S., 2001. Journal of Biological Chemistry, 276 (49) pp. 46485-46494. Peer-reviewed.
 
Catechol-binding serines of beta(2)-adrenergic receptors control the equilibrium between active and inactive receptor states.
Ambrosio C., Molinari P., Cotecchia S., Costa T., 2000. Molecular Pharmacology, 57 (1) pp. 198-210.
 
Comparison of [3H]tamsulosin and [3H]prazosin binding to wild-type and constitutively active alpha1B-adrenoceptors.
Hein P., Goepel M., Cotecchia S., Michel M.C., 2000. Life Sciences, 67 (5) pp. 503-508.
 
Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation.
Scheer A., Costa T., Fanelli F., De Benedetti P.G., Mhaouty-Kodja S., Abuin L., Nenniger-Tosato M., Cotecchia S., 2000. Molecular Pharmacology, 57 (2) pp. 219-231.
 
The alpha 1a and alpha 1b-adrenergic receptor subtypes: molecular mechanisms of receptor activation and of drug action.
Cotecchia S., Rossier O., Fanelli F., Leonardi A., De Benedetti P.G., 2000. Pharmaceutica Acta Helvetiae, 74 (2-3) pp. 173-179.
 
The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor.
Alewijnse A.E., Timmerman H., Jacobs E.H., Smit M.J., Roovers E., Cotecchia S., Leurs R., 2000. Molecular Pharmacology, 57 (5) pp. 890-898.
 
Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor.
Pralong F.P., Gomez F., Castillo E., Cotecchia S., Abuin L., Aubert M.L., Portmann L., Gaillard R.C., 1999. Journal of Clinical Endocrinology and Metabolism, 84 (10) pp. 3811-3816.
 
Constitutively active alpha-1b adrenergic receptor mutants display different phosphorylation and internalization features.
Mhaouty-Kodja S., Barak L.S., Scheer A., Abuin L., Diviani D., Caron M.G., Cotecchia S., 1999. Molecular Pharmacology, 55 (2) pp. 339-347.
 
Constitutively active mutants of the beta1-adrenergic receptor.
Lattion A., Abuin L., Nenniger-Tosato M., Cotecchia S., 1999. FEBS Letters, 457 (3) pp. 302-306.
 
Constitutively active receptor mutants as probes to study the mechanisms underlying GPCR activation
Cotecchia S., Fanelli F., Scheer A., De Benedetti P. G., 1999. 167-183.
 
Expression of the alpha 1b-adrenergic receptor and G protein subunits in mammalian cell lines using the Semliki Forest virus expression system.
Scheer A., Björklöf K., Cotecchia S., Lundstrom K., 1999. Journal of Receptor and Signal Transduction Research, 19 (1-4) pp. 369-378.
 
Inverse agonism and neutral antagonism at alpha(1a)- and alpha(1b)-adrenergic receptor subtypes.
Rossier O., Abuin L., Fanelli F., Leonardi A., Cotecchia S., 1999. Molecular Pharmacology, 56 (5) pp. 858-866.
 
Regulatory mechanisms of alpha 1B-adrenergic receptor function.
Cotecchia S., Mhaouty-Kodja S., 1999. Biochemical Society Transactions, 27 (2) pp. 154-157.
 
Structure-function relationships of the alpha1b-adrenergic receptor.
Scheer A., Fanelli F., Diviani D., de Benedetti P.G., Cotecchia S., 1999. European Urology, 36 Suppl 1 pp. 11-16.
 
Theoretical study of the electrostatically driven step of receptor-G protein recognition.
Fanelli F., Menziani C., Scheer A., Cotecchia S., De Benedetti P.G., 1999. Proteins, 37 (2) pp. 145-156.
 
Theoretical study on receptor-G protein recognition: new insights into the mechanisms of the alpha1b-adrenergic recptor activation
Fanelli F., Menziani C., Scheer A., Cotecchia S., De Benedetti P. G., 1999. International Journal of Quantum Chemistry, 73 (2) pp. 71-83.
 
Ab initio modeling and molecular dynamics simulation of the alpha 1b-adrenergic receptor activation.
Fanelli F., Menziani C., Scheer A., Cotecchia S., De Benedetti P.G., 1998. Methods, 14 (3) pp. 302-317.
 
Molecular mechanisms involved in the activation and regulation of the alpha 1-adrenergic receptor subtypes.
Cotecchia S., Scheer A., Diviani D., Fanelli F., De Benedetti P.G., 1998. Farmaco, 53 (4) pp. 273-277.
 
Murine alpha1-adrenoceptor subtypes. I. Radioligand binding studies.
Yang M., Reese J., Cotecchia S., Michel M.C., 1998. Journal of Pharmacology and Experimental Therapeutics, 286 (2) pp. 841-847.
 
Characterization of the phosphorylation sites involved in G protein-coupled receptor kinase- and protein kinase C-mediated desensitization of the alpha1B-adrenergic receptor.
Diviani D., Lattion A.L., Cotecchia S., 1997. Journal of Biological Chemistry, 272 (45) pp. 28712-28719.
 
Constitutively active G protein-coupled receptors: potential mechanisms of receptor activation.
Scheer A., Cotecchia S., 1997. Journal of Receptor and Signal Transduction Research, 17 (1-3) pp. 57-73.
 
Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor.
Cavalli A., Lattion A.L., Hummler E., Nenniger M., Pedrazzini T., Aubert J.F., Michel M.C., Yang M., Lembo G., Vecchione C. et al., 1997. Proceedings of the National Academy of Sciences of the United States of America, 94 (21) pp. 11589-11594. Peer-reviewed.
 
The activation process of the alpha1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate.
Scheer A., Fanelli F., Costa T., De Benedetti P.G., Cotecchia S., 1997. Proceedings of the National Academy of Sciences of the United States of America, 94 (3) pp. 808-813.
 
Up-regulation of the levels of expression and function of a constitutively active mutant of the hamster alpha1B-adrenoceptor by ligands that act as inverse agonists.
Lee T.W., Cotecchia S., Milligan G., 1997. Biochemical Journal, 325 (3) pp. 733-739.
 
Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation.
Scheer A., Fanelli F., Costa T., De Benedetti P.G., Cotecchia S., 1996/07. EMBO Journal, 15 (14) pp. 3566-3578.
 
A constitutively active mutant of the alpha 1B-adrenergic receptor can cause greater agonist-dependent down-regulation of the G-proteins G9 alpha and G11 alpha than the wild-type receptor.
Lee T.W., Wise A., Cotecchia S., Milligan G., 1996. Biochemical Journal, 320 (1) pp. 79-86.
 
Adrenergic, dopaminergic, and muscarinic receptor stimulation leads to PKA phosphorylation of Na-K-ATPase.
Beguin P., Beggah A., Cotecchia S., Geering K., 1996. American Journal of Physiology, 270 (1 Pt 1) pp. C131-C137.
 
Amino acids of the alpha1B-adrenergic receptor involved in agonist binding: differences in docking catecholamines to receptor subtypes.
Cavalli A., Fanelli F., Taddei C., De Benedetti P.G., Cotecchia S., 1996. FEBS Letters, 399 (1-2) pp. 9-13.
 
Effect of different G protein-coupled receptor kinases on phosphorylation and desensitization of the alpha1B-adrenergic receptor.
Diviani D., Lattion A.L., Larbi N., Kunapuli P., Pronin A., Benovic J.L., Cotecchia S., 1996. Journal of Biological Chemistry, 271 (9) pp. 5049-5058.
 
Signalling and regulation of the alpha 1B-adrenergic receptor.
Cotecchia S., Lattion A.L., Diviani D., Cavalli A., 1995. Biochemical Society Transactions, 23 (1) pp. 121-125.
 
Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor.
Samama P., Pei G., Costa T., Cotecchia S., Lefkowitz R.J., 1994. Molecular Pharmacology, 45 (3) pp. 390-394.
 
Phosphorylation of the Na,K-ATPase alpha-subunit by protein kinase A and C in vitro and in intact cells. Identification of a novel motif for PKC-mediated phosphorylation.
Beguin P., Beggah A.T., Chibalin A.V., Burgener-Kairuz P., Jaisser F., Mathews P.M., Rossier B.C., Cotecchia S., Geering K., 1994. Journal of Biological Chemistry, 269 (39) pp. 24437-24445.
 
Truncation of the receptor carboxyl terminus impairs agonist-dependent phosphorylation and desensitization of the alpha 1B-adrenergic receptor.
Lattion A.L., Diviani D., Cotecchia S., 1994. Journal of Biological Chemistry, 269 (36) pp. 22887-22893.
 
Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins.
Lefkowitz R.J., Cotecchia S., Samama P., Costa T., 1993. Trends in Pharmacological Sciences, 14 (8) pp. 303-307.
 
Constitutively active mutants of the alpha 2-adrenergic receptor.
Ren Q., Kurose H., Lefkowitz R.J., Cotecchia S., 1993. Journal of Biological Chemistry, 268 (22) pp. 16483-16487. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University